Restarting and timing of oral anticoagulation after traumatic intracranial hemorrhage: a review and summary of ongoing and planned prospective randomized clinical trials

Anticoagulant-associated traumatic intracranial hemorrhage (tICrH) is a devastating injury with high morbidity and mortality. For survivors, treating clinicians face the dilemma of restarting oral anticoagulation with scarce evidence to guide them. Thromboembolic risk is high from the bleeding event...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Ben, Milling, Truman, Gajewski, Byron, Costantini, Todd W, Wick, Jo, Price, Michelle A, Mudaranthakam, Dinesh, Stein, Deborah M, Connolly, Stuart, Valadka, Alex, Warach, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716676/
https://www.ncbi.nlm.nih.gov/pubmed/33313417
http://dx.doi.org/10.1136/tsaco-2020-000605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716676/
https://www.ncbi.nlm.nih.gov/pubmed/33313417
http://dx.doi.org/10.1136/tsaco-2020-000605

Ejemplares similares